LUAN BROWN: Open Payments
NPI 1811439490 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 85 payments from 16 companies in 2025. Trend: 2023 $1,204 · 2024 $1,567 · 2025 $1,589
Food & beverage: $1,512Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $346 |
| ABBVIE INC. | 19 | $286 |
| Aimmune Therapeutics, Inc. | 11 | $286 |
| Ardelyx, Inc. | 10 | $191 |
| GENZYME CORPORATION | 8 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
Products named: TREMFYA, ZENPEP, IBSRELA, DUPIXENT, RINVOQ, XIFAXAN, SKYRIZI, LINZESS.
Industry payments across MS — which companies pay providers there.
